8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41)
Key Takeaways
- Theft or significant loss of controlled substances must be reported in writing to the DEA within 1 business day of discovery, followed by electronic Form 106 submission.
- Supplier is responsible for reporting in-transit losses before delivery receipt; purchaser is responsible after signing for delivery.
- Controlled substance disposal must be conducted via a DEA-registered Reverse Distributor or approved destruction process.
- Transferring Schedule II drugs to a reverse distributor requires the reverse distributor to issue DEA Form 222 to the pharmacy.
- DEA Form 41 is executed by the reverse distributor (or registrant) to certify final non-retrievable drug destruction.
8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41)
Controlled substances present significant diversion risks. The DEA enforces strict protocols for reporting inventory shortages resulting from theft or significant loss (21 CFR § 1301.76) and for disposing of expired, damaged, or unwanted controlled stock (21 CFR Part 1317). Pharmacists must master the distinct roles of DEA Form 106 and DEA Form 41.
Reporting Theft or Significant Loss: The 1 Business Day Rule
When a pharmacy discovers a theft or significant loss of controlled substances, federal law imposes an immediate notification obligation.
Mandatory Timeline:
- Initial Written Notification: The pharmacy must notify the local DEA Field Division in writing within ONE BUSINESS DAY of discovery of the theft or significant loss.
- Written notification may be transmitted via email, fax, or official DEA online portal.
- Local law enforcement and the state board of pharmacy should also be notified per state requirements.
- Formal Report (DEA Form 106): After conducting an internal investigation to gather details, the pharmacy submits DEA Form 106 electronically via the DEA secure application.
- If an initial notification was submitted but investigation reveals that no theft or loss actually occurred, or that the loss was not significant, the pharmacy is not required to submit Form 106. However, the pharmacy must notify the DEA in writing explaining why Form 106 was not filed.
Determining "Significant Loss"
The DEA does not establish a fixed numerical quantity to define a "significant loss." Instead, the registrant must evaluate the following legal criteria:
- Specific drug quantity lost: (e.g., 5 tablets of hydrocodone vs. 1,000 tablets).
- Specific drug schedule and abuse potential: Loss of Schedule II opioids (fentanyl, oxycodone) carries higher significance than Schedule V antitussives.
- Likelihood of diversion: Whether the missing drugs are likely targeted for illicit street distribution.
- Patterns of loss: Repeated small losses occurring over a specific time frame (e.g., recurring inventory variances tied to specific shifts or personnel).
- Individual responsibility: Whether the loss is bound to specific individuals or unknown access points.
In-Transit Loss Responsibilities
When controlled substances are stolen or lost during transport between a wholesaler/supplier and a pharmacy, legal responsibility depends on custody transfer:
| Scenario | Responsible Party | Required Action |
|---|---|---|
| Loss before purchaser signs delivery receipt | Supplier (Wholesaler) | Supplier submits DEA Form 106 |
| Loss after purchaser signs delivery receipt | Purchaser (Pharmacy) | Purchaser submits DEA Form 106 |
| Central Fill Shipment Loss | Central Fill Pharmacy or Retail Pharmacy | Depends on contract carrier arrangement and custody transfer point |
Disposal and Destruction Standards
Under the Secure and Responsible Drug Disposal Act of 2010 and 21 CFR Part 1317, pharmacies cannot destroy controlled substances by flushing them down drains or discarding them in standard trash. Destruction must render the drug non-retrievable (permanently altering the substance's physical or chemical condition so it cannot be recovered or reconstituted).
Primary Disposal Route: DEA-Registered Reverse Distributor
The standard and most common method for pharmacy controlled substance disposal is transferring stock to a DEA-Registered Reverse Distributor.
Transfer Protocols:
- Schedule II Transfer: The reverse distributor acts as the purchaser and must issue a DEA Form 222 (or CSOS order) to the pharmacy. The pharmacy acts as the supplier and fills the Form 222 by shipping the expired/damaged CII items.
- Schedule III–V Transfer: Documented via an invoice or manifest recording drug name, dosage form, strength, quantity, and transfer date.
- Form 41 Execution: The Reverse Distributor—not the pharmacy—is responsible for submitting DEA Form 41 to the DEA once the controlled substances have been physically destroyed.
Secondary Disposal Route: Registrant On-Site Destruction
If a pharmacy wishes to destroy controlled substances on-site:
- The pharmacy must request prior authorization from the local DEA Special Agent in Charge using DEA Form 41.
- Destruction must be witnessed by two authorized employees (at least one licensed pharmacist).
- Form 41 must document the drug details, method of destruction, and signatures of both witnesses.
Accidental Breakage and Spillage
Accidental breakage or spillage of controlled substances (e.g., dropping a liquid methadone bottle or crushing tablets) is NOT considered a theft or significant loss:
- Do NOT file DEA Form 106 for accidental breakage/spillage unless drugs were stolen.
- Recoverable Waste: If spilled drug residue is recoverable, it must be disposed of via a reverse distributor and recorded on DEA Form 41.
- Unrecoverable Waste: If liquid is absorbed into carpet or washed away, the event must be documented in pharmacy records signed by two witnessing employees explaining the incident.
A pharmacy experiences a burglary overnight resulting in theft of Schedule II opioids. Under DEA regulations (21 CFR § 1301.76), what is the initial reporting deadline to notify the DEA?
Controlled substances ordered by a pharmacy are stolen from the delivery truck before the pharmacy signs the delivery receipt. Who is legally responsible for reporting this in-transit loss on DEA Form 106?
When a pharmacy transfers expired Schedule II controlled substances to a DEA-registered reverse distributor for destruction, which document must be executed to transfer legal custody?
A pharmacy technician accidentally drops a 500 mL bottle of liquid methadone onto the floor, shattering the container and spilling the liquid completely across the carpet. How should the pharmacy document this event under DEA rules?